#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?

Kushala W. M. Abeysekera; Jessica Shearer; Oliver D. Tavabie; John F. Dillon; Ian A. Rowe

doi:10.1136/flgastro-2022-102330

#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?

Kushala W. M. Abeysekera, Jessica Shearer, Oliver D. Tavabie (Lead / Corresponding author), John F. Dillon, Ian A. Rowe

Molecular and Clinical Medicine

Research output: Contribution to journal › Comment/debate › peer-review

6 Downloads (Pure)

Abstract

The #FGDebate series featured ‘Controversies in detecting patients with liver disease’ which was inspired by the recent review from Macpherson et al.1 The debate was well attended and generated 1.35 million impressions across Twitter, which placed it within the top 10 #FGDebate of all time for total impressions made. The main topic for debate was whether we should focus on detecting patients at risk of liver disease in the community. Here, we aim to provide arguments for and against this issue.

Original language	English
Article number	102330
Number of pages	3
Journal	Frontline Gastroenterology
Early online date	1 Dec 2022
DOIs	https://doi.org/10.1136/flgastro-2022-102330
Publication status	E-pub ahead of print - 1 Dec 2022

Keywords

Chronic Liver Disease
Screening

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1136/flgastro-2022-102330

Author Accepted ManuscriptAccepted author manuscript, 247 KBLicence: CC BY-NC

Cite this

@article{d2acccc811044feb83bcbc223b6bf5ca,

title = "#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?",

abstract = "The #FGDebate series featured {\textquoteleft}Controversies in detecting patients with liver disease{\textquoteright} which was inspired by the recent review from Macpherson et al.1 The debate was well attended and generated 1.35 million impressions across Twitter, which placed it within the top 10 #FGDebate of all time for total impressions made. The main topic for debate was whether we should focus on detecting patients at risk of liver disease in the community. Here, we aim to provide arguments for and against this issue.",

keywords = "Chronic Liver Disease, Screening",

author = "Abeysekera, {Kushala W. M.} and Jessica Shearer and Tavabie, {Oliver D.} and Dillon, {John F.} and Rowe, {Ian A.}",

note = "Copyright: {\textcopyright} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2022",

month = dec,

day = "1",

doi = "10.1136/flgastro-2022-102330",

language = "English",

journal = "Frontline Gastroenterology",

issn = "2041-4137",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - #FGDebate

T2 - Should we focus on detecting patients at risk of liver disease in the community?

AU - Abeysekera, Kushala W. M.

AU - Shearer, Jessica

AU - Tavabie, Oliver D.

AU - Dillon, John F.

AU - Rowe, Ian A.

PY - 2022/12/1

Y1 - 2022/12/1

N2 - The #FGDebate series featured ‘Controversies in detecting patients with liver disease’ which was inspired by the recent review from Macpherson et al.1 The debate was well attended and generated 1.35 million impressions across Twitter, which placed it within the top 10 #FGDebate of all time for total impressions made. The main topic for debate was whether we should focus on detecting patients at risk of liver disease in the community. Here, we aim to provide arguments for and against this issue.

AB - The #FGDebate series featured ‘Controversies in detecting patients with liver disease’ which was inspired by the recent review from Macpherson et al.1 The debate was well attended and generated 1.35 million impressions across Twitter, which placed it within the top 10 #FGDebate of all time for total impressions made. The main topic for debate was whether we should focus on detecting patients at risk of liver disease in the community. Here, we aim to provide arguments for and against this issue.

KW - Chronic Liver Disease

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85144957158&partnerID=8YFLogxK

U2 - 10.1136/flgastro-2022-102330

DO - 10.1136/flgastro-2022-102330

M3 - Comment/debate

AN - SCOPUS:85144957158

SN - 2041-4137

JO - Frontline Gastroenterology

JF - Frontline Gastroenterology

M1 - 102330

ER -

#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this